News & Events

Learn more about TriNetX through media coverage and upcoming events

News & Events

Learn more about TriNetX through media coverage and upcoming events

Press Releases

Anshul Thakral Appointed to the TriNetX Board of Directors

Cambridge, MA, May 5, 2022 — TriNetX, LLC, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced the appointment of Anshul Thakral to the company’s board of directors. Mr. Thakral...

Blood Cancer Journal Study Finds Multiple Myeloma Patients at Higher Risk of COVID-19 Infection and Mortality

TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, enabled researchers at Hospital Universitario 12 de Octubre to leverage European real-world data for a study that found that multiple myeloma (MM) patients were more likely to contract the COVID-19 virus and suffer a higher risk of mortality than non-MM patients.

Blog

Recent Scientific Publications

Harrison, S. Fazio-Eynullayeva, E., Lane, D., Underhill, P., Lip, G. “Atrial fibrillation and the risk of 30‐day incident thromboembolic events, and mortality in adults ≥ 50 years with COVID‐19.” Published in Journal of Arrhythmia, 11 December 2020.

Applebaum, L., Berg, A., Cambronero, J., Dang, T., Jin, C., Zhang, L., Palchuk, M., Kundrot, S., Evans, L., Kaplan, I., Rinard, M. “Development of a pancreatic cancer prediction model using a multinational medical records database.” Journal of Clinical Oncology 2021 39:3_suppl, 394-394. 22 January 2021.

Pakhchanian, H., Raiker, R., Mukherjee, A., Khan, A., Singh, S., Chatterjee, A. “Outcomes of COVID-19 in CKD Patients.”. CJASN Feb 2021, CJN.13820820; DOI: 10.2215/CJN.13820820. February 2021.

QUICK SEARCH OUR LIBRARY
thinking